SAAL1
gene geneOn this page
Also known as FLJ41463SPACIA1
Summary
SAAL1 (serum amyloid A like 1, HGNC:25158) is a protein-coding gene on chromosome 11p15.1, encoding Protein SAAL1 (Q96ER3). Plays a role in promoting the proliferation of synovial fibroblasts in response to pro-inflammatory stimuli.
Acts upstream of or within positive regulation of synoviocyte proliferation. Located in nucleoplasm.
Source: NCBI Gene 113174 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 62 total
- Druggable target: yes
- MANE Select transcript:
NM_138421
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25158 |
| Approved symbol | SAAL1 |
| Name | serum amyloid A like 1 |
| Location | 11p15.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ41463, SPACIA1 |
| Ensembl gene | ENSG00000166788 |
| Ensembl biotype | protein_coding |
| Entrez | 113174 |
Gene structure
Transcript identifiers
Ensembl transcripts: 31 — 23 protein_coding, 4 protein_coding_CDS_not_defined, 3 retained_intron, 1 nonsense_mediated_decay
ENST00000300013, ENST00000524803, ENST00000528002, ENST00000529318, ENST00000530180, ENST00000530237, ENST00000530436, ENST00000530736, ENST00000531216, ENST00000531581, ENST00000531751, ENST00000532403, ENST00000532452, ENST00000533851, ENST00000534721, ENST00000898174, ENST00000898175, ENST00000940259, ENST00000940260, ENST00000940261, ENST00000940262, ENST00000940263, ENST00000940264, ENST00000940265, ENST00000940266, ENST00000940267, ENST00000940268, ENST00000940269, ENST00000940270, ENST00000940271, ENST00000940272
RefSeq mRNA: 1 — MANE Select: NM_138421
NM_138421
CCDS: CCDS31439
Canonical transcript exons
ENST00000524803 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001106592 | 18089330 | 18089510 |
| ENSE00001106596 | 18083535 | 18083731 |
| ENSE00001106598 | 18090175 | 18090290 |
| ENSE00001106600 | 18087143 | 18087225 |
| ENSE00002156541 | 18080292 | 18080491 |
| ENSE00002164197 | 18105907 | 18106082 |
| ENSE00003477042 | 18090434 | 18090493 |
| ENSE00003496112 | 18103233 | 18103346 |
| ENSE00003558859 | 18092245 | 18092324 |
| ENSE00003680373 | 18081411 | 18081503 |
| ENSE00003682118 | 18086866 | 18087054 |
| ENSE00003684745 | 18096771 | 18096854 |
Expression profiles
Bgee: expression breadth ubiquitous, 205 present calls, max score 92.83.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.7669 / max 210.8419, expressed in 1798 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 118911 | 15.7669 | 1798 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 92.83 | gold quality |
| ganglionic eminence | UBERON:0004023 | 90.74 | gold quality |
| ventricular zone | UBERON:0003053 | 90.42 | gold quality |
| ileal mucosa | UBERON:0000331 | 89.70 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.40 | gold quality |
| tibialis anterior | UBERON:0001385 | 89.26 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 89.11 | gold quality |
| cerebellar cortex | UBERON:0002129 | 88.86 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 88.84 | gold quality |
| calcaneal tendon | UBERON:0003701 | 88.68 | gold quality |
| left ovary | UBERON:0002119 | 88.41 | gold quality |
| cortical plate | UBERON:0005343 | 88.36 | gold quality |
| tibial nerve | UBERON:0001323 | 88.28 | gold quality |
| rectum | UBERON:0001052 | 87.97 | gold quality |
| right ovary | UBERON:0002118 | 87.94 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 87.89 | gold quality |
| body of uterus | UBERON:0009853 | 87.56 | gold quality |
| granulocyte | CL:0000094 | 86.97 | gold quality |
| body of pancreas | UBERON:0001150 | 86.85 | gold quality |
| endocervix | UBERON:0000458 | 86.80 | gold quality |
| right uterine tube | UBERON:0001302 | 86.69 | gold quality |
| cerebellum | UBERON:0002037 | 86.68 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 86.65 | gold quality |
| bone marrow cell | CL:0002092 | 86.42 | gold quality |
| ectocervix | UBERON:0012249 | 86.21 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 85.88 | gold quality |
| left testis | UBERON:0004533 | 85.82 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 85.66 | gold quality |
| spleen | UBERON:0002106 | 85.65 | gold quality |
| ovary | UBERON:0000992 | 85.61 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.71 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Overexpression of SPACIA1/SAAL1, a newly identified gene that is involved in synoviocyte proliferation, accelerates the progression of synovitis in mice and humans. (PMID:22127701)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | saal1 | ENSDARG00000018681 |
| mus_musculus | Saal1 | ENSMUSG00000006763 |
| drosophila_melanogaster | CG30467 | FBGN0050467 |
Paralogs (3): SAA2 (ENSG00000134339), SAA4 (ENSG00000148965), SAA1 (ENSG00000173432)
Protein
Protein identifiers
Protein SAAL1 — Q96ER3 (reviewed: Q96ER3)
Alternative names: Synoviocyte proliferation-associated in collagen-induced arthritis protein 1
All UniProt accessions (9): Q96ER3, E9PL53, E9PMD2, E9PRZ1, G1UCX3, H0YCN7, H0YDM3, H0YEK5, J3KND1
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in promoting the proliferation of synovial fibroblasts in response to pro-inflammatory stimuli.
Subcellular location. Nucleus.
Tissue specificity. Highly expressed in testis and ovary, and to a lesser extent in the lung, spleen and the heart (at protein level).
Similarity. Belongs to the SAAL1 family.
RefSeq proteins (1): NP_612430* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011989 | ARM-like | Homologous_superfamily |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR052464 | Synovial_Prolif_Regulator | Family |
UniProt features (8 total): modified residue 2, sequence variant 2, chain 1, region of interest 1, compositionally biased region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96ER3-F1 | 85.81 | 0.69 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 6, 387
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 81 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP, GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, WEI_MYCN_TARGETS_WITH_E_BOX, FISCHER_DREAM_TARGETS, GOBP_EPITHELIAL_CELL_PROLIFERATION, RASHI_RESPONSE_TO_IONIZING_RADIATION_6, TGATTTRY_GFI1_01, GOBP_POSITIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION, GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_UP, ARID5B_TARGET_GENES, SFMBT1_TARGET_GENES, SKIL_TARGET_GENES, SNIP1_TARGET_GENES
GO Biological Process (1): positive regulation of synoviocyte proliferation (GO:1901647)
GO Molecular Function (0):
GO Cellular Component (3): nucleus (GO:0005634), nucleoplasm (GO:0005654), collagen trimer (GO:0005581)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| synoviocyte proliferation | 1 |
| positive regulation of epithelial cell proliferation | 1 |
| regulation of synoviocyte proliferation | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
842 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SAAL1 | PRAMEF20 | Q5VT98 | 519 |
| SAAL1 | TMEM19 | Q96HH6 | 506 |
| SAAL1 | ASGR2 | P07307 | 494 |
| SAAL1 | SLA | Q13239 | 475 |
| SAAL1 | SERGEF | Q9UGK8 | 463 |
| SAAL1 | TANGO6 | Q9C0B7 | 438 |
| SAAL1 | SAA4 | P35542 | 436 |
| SAAL1 | ASGR1 | P07306 | 420 |
| SAAL1 | OR51A2 | Q8NGJ7 | 418 |
| SAAL1 | PLEKHM3 | Q6ZWE6 | 407 |
| SAAL1 | APOC1 | P02654 | 399 |
| SAAL1 | ISOC1 | Q96CN7 | 398 |
| SAAL1 | VLDLR | P98155 | 396 |
| SAAL1 | APOC3 | P02656 | 385 |
| SAAL1 | ZER1 | Q7Z7L7 | 381 |
IntAct
172 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:0914”(association) | 0.710 |
| SNW1 | AQR | psi-mi:“MI:0914”(association) | 0.650 |
| TNFSF13B | IPO8 | psi-mi:“MI:0914”(association) | 0.640 |
| CD68 | TTI1 | psi-mi:“MI:0914”(association) | 0.640 |
| PMPCB | psi-mi:“MI:0914”(association) | 0.640 | |
| CD27 | TCAF2 | psi-mi:“MI:0914”(association) | 0.640 |
| SCN2B | EXOC5 | psi-mi:“MI:0914”(association) | 0.640 |
| ZFPL1 | PPP2R5E | psi-mi:“MI:0914”(association) | 0.640 |
| B3GAT3 | GOLIM4 | psi-mi:“MI:0914”(association) | 0.640 |
| CD68 | LGALS1 | psi-mi:“MI:0914”(association) | 0.640 |
| GYPA | TCAF2 | psi-mi:“MI:0914”(association) | 0.640 |
| SLC16A3 | CASK | psi-mi:“MI:0914”(association) | 0.590 |
| CD4 | CCDC85C | psi-mi:“MI:0914”(association) | 0.530 |
| EPHA1 | EXOC5 | psi-mi:“MI:0914”(association) | 0.530 |
| PTGER3 | PIK3R2 | psi-mi:“MI:0914”(association) | 0.530 |
| VASN | AP3B1 | psi-mi:“MI:0914”(association) | 0.530 |
| FZD10 | NRP1 | psi-mi:“MI:0914”(association) | 0.530 |
| VSIG2 | TTI1 | psi-mi:“MI:0914”(association) | 0.530 |
| COMTD1 | IFRD1 | psi-mi:“MI:0914”(association) | 0.530 |
| CA14 | EXOC5 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (243): SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS), SAAL1 (Affinity Capture-MS)
ESM2 similar proteins: A0A5F9C6I2, A1L3F5, A2RT67, A4IIA7, A6NHR9, A7MBJ1, A8K855, D3ZXK7, F4JSE7, O08658, O14893, O75165, P0C8M4, P49021, Q0P410, Q3UD82, Q4R5A4, Q568D5, Q5F3F2, Q5R9R1, Q5RC14, Q5VVJ2, Q5XI20, Q5XPI3, Q5XPI4, Q5ZJK1, Q66J91, Q66KJ5, Q69Z66, Q6GPL9, Q7TMY8, Q7TNH6, Q7Z494, Q7Z6Z7, Q7ZX36, Q8BHR8, Q8CDG3, Q8CEC0, Q8CF97, Q8CGA4
Diamond homologs: Q6DCP5, Q6NVK9, Q803M5, Q96ER3, Q9D2C2
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SAAL1 | “up-regulates quantity by expression” | CDK6 | “post transcriptional regulation” |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 179 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| T cell costimulation | 6 | 14.7× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
62 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2374 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:18080490:ACCTG:A | acceptor_loss | 1.0000 |
| 11:18080491:CCTGT:C | acceptor_loss | 1.0000 |
| 11:18080492:CT:C | acceptor_loss | 1.0000 |
| 11:18080493:T:G | acceptor_loss | 1.0000 |
| 11:18081403:ATAC:A | donor_loss | 1.0000 |
| 11:18081404:TACT:T | donor_loss | 1.0000 |
| 11:18081405:ACT:A | donor_loss | 1.0000 |
| 11:18081406:CTCA:C | donor_loss | 1.0000 |
| 11:18081409:ACCAC:A | donor_loss | 1.0000 |
| 11:18081410:C:CT | donor_loss | 1.0000 |
| 11:18081410:CCA:C | donor_gain | 1.0000 |
| 11:18081501:CTC:C | acceptor_gain | 1.0000 |
| 11:18081503:CCTAA:C | acceptor_loss | 1.0000 |
| 11:18081504:C:CA | acceptor_loss | 1.0000 |
| 11:18081504:C:CC | acceptor_gain | 1.0000 |
| 11:18081505:T:C | acceptor_loss | 1.0000 |
| 11:18083580:AT:A | donor_gain | 1.0000 |
| 11:18083581:T:TA | donor_gain | 1.0000 |
| 11:18087055:C:CC | acceptor_gain | 1.0000 |
| 11:18087056:T:C | acceptor_gain | 1.0000 |
| 11:18087059:A:C | acceptor_gain | 1.0000 |
| 11:18087221:CAGAA:C | acceptor_gain | 1.0000 |
| 11:18087226:C:CC | acceptor_gain | 1.0000 |
| 11:18089326:CTA:C | donor_loss | 1.0000 |
| 11:18089327:TA:T | donor_loss | 1.0000 |
| 11:18089328:A:AC | donor_gain | 1.0000 |
| 11:18089329:C:CC | donor_gain | 1.0000 |
| 11:18089329:CCGTA:C | donor_gain | 1.0000 |
| 11:18089333:A:AC | donor_gain | 1.0000 |
| 11:18089334:C:CC | donor_gain | 1.0000 |
AlphaMissense
3156 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:18103251:C:A | W77C | 0.999 |
| 11:18103251:C:G | W77C | 0.999 |
| 11:18103253:A:G | W77R | 0.999 |
| 11:18103253:A:T | W77R | 0.999 |
| 11:18090247:A:G | W173R | 0.998 |
| 11:18090247:A:T | W173R | 0.998 |
| 11:18096838:A:G | L89P | 0.996 |
| 11:18103249:T:G | D78A | 0.996 |
| 11:18090434:C:A | R158M | 0.995 |
| 11:18090434:C:G | R158T | 0.995 |
| 11:18092298:A:C | N120K | 0.995 |
| 11:18092298:A:T | N120K | 0.995 |
| 11:18090290:C:A | R158S | 0.994 |
| 11:18090290:C:G | R158S | 0.994 |
| 11:18092262:G:C | S132R | 0.994 |
| 11:18092262:G:T | S132R | 0.994 |
| 11:18092264:T:G | S132R | 0.994 |
| 11:18092312:C:G | G116R | 0.994 |
| 11:18092312:C:T | G116R | 0.994 |
| 11:18103249:T:A | D78V | 0.994 |
| 11:18103250:C:G | D78H | 0.994 |
| 11:18092302:C:T | G119D | 0.993 |
| 11:18092311:C:T | G116E | 0.992 |
| 11:18096828:A:C | F92L | 0.992 |
| 11:18096828:A:T | F92L | 0.992 |
| 11:18096830:A:G | F92L | 0.992 |
| 11:18096847:G:T | A86D | 0.992 |
| 11:18103244:A:G | S80P | 0.992 |
| 11:18103248:A:C | D78E | 0.991 |
| 11:18103248:A:T | D78E | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000105033 (11:18105527 T>C), RS1000141027 (11:18105206 G>A,C,T), RS1000169912 (11:18086797 G>T), RS1000412021 (11:18098975 T>C), RS1000508834 (11:18095155 T>A,C), RS1000525912 (11:18082520 A>T), RS1000579062 (11:18082215 A>G), RS1000689889 (11:18099700 G>C), RS1000945879 (11:18094409 A>G), RS1001112955 (11:18106407 G>A), RS1001126247 (11:18097850 A>C), RS1001135234 (11:18086726 AAAAT>A), RS1001241168 (11:18088780 G>A,C), RS1001310752 (11:18093302 T>C), RS1001386054 (11:18100799 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6067380 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression, decreases methylation, increases expression | 3 |
| sodium arsenite | increases expression, decreases expression, affects cotreatment, increases abundance | 3 |
| Arsenic | affects cotreatment, increases abundance, increases expression, affects methylation | 2 |
| Valproic Acid | affects expression, increases expression | 2 |
| dicrotophos | decreases expression | 1 |
| K 7174 | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Coumestrol | increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Lead | affects expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652377 | Binding | Binding affinity to human SAAL1 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.